View Single Post
Old 07-26-2016, 07:51 AM
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Post Newron to resubmit troubled Parkinson's drug to FDA; abuse risks cleared - FierceBiot


FierceBiotech


Newron to resubmit troubled Parkinson's drug to FDA; abuse risks cleared
FierceBiotech
Newron Pharmaceuticals has seen a much needed quick turnaround for its lead Parkinson's drug as it can now resubmit its candidate in the U.S.--just four months after being blocked by the FDA. The Italian biotech's drug, which will be marketed as Xadago ...
Newron to Re-Submit US NDA for Xadago® (Safinamide)Business Wire (press release)

all 2 news articles »


More...
NewsBot is offline   Reply With QuoteReply With Quote